Cargando…

NR4A1-3 nuclear receptor activity and immune cell dysregulation in rheumatic diseases

The development and progression of immune-mediated rheumatic disease (IMRD) involves dysfunction of innate and adaptive immune cell populations leading to altered responses including inflammasome activation, dysregulated cytokine networks, increased immune cell numbers and multifaceted cell-cell com...

Descripción completa

Detalles Bibliográficos
Autores principales:	Murphy, Evelyn P., Crean, Daniel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9354819/ https://www.ncbi.nlm.nih.gov/pubmed/35935773 http://dx.doi.org/10.3389/fmed.2022.874182

Ejemplares similares

Targeting NR4A Nuclear Receptors to Control Stromal Cell Inflammation, Metabolism, Angiogenesis, and Tumorigenesis
por: Crean, Daniel, et al.
Publicado: (2021)

Molecular Interactions between NR4A Orphan Nuclear Receptors and NF-κB Are Required for Appropriate Inflammatory Responses and Immune Cell Homeostasis
por: Murphy, Evelyn P., et al.
Publicado: (2015)

Transcriptional Profiling of Monocytes Deficient in Nuclear Orphan Receptors NR4A2 and NR4A3 Reveals Distinct Signalling Roles Related to Antigen Presentation and Viral Response
por: Phelan, David E., et al.
Publicado: (2021)

NR4A Receptors Differentially Regulate NF-κB Signaling in Myeloid Cells
por: McEvoy, Caitriona, et al.
Publicado: (2017)

Transcriptomic Analysis Shows Decreased Cortical Expression of NR4A1, NR4A2 and RXRB in Schizophrenia and Provides Evidence for Nuclear Receptor Dysregulation
por: Corley, Susan M., et al.
Publicado: (2016)

Nuclear receptors of NR1 and NR4 subfamilies in the regulation of microglial functions and pathology
por: Katsuki, Hiroshi
Publicado: (2021)

Nuclear receptor NR4A is required for patterning at the ends of the planarian anterior-posterior axis
por: Li, Dayan J, et al.
Publicado: (2019)

COVID-19, rheumatic diseases and immune dysregulation—a perspective
por: Tariq, Shahna, et al.
Publicado: (2021)

In Silico Adoption of an Orphan Nuclear Receptor NR4A1
por: Lanig, Harald, et al.
Publicado: (2015)

Targeting Orphan Nuclear Receptors NR4As for Energy Homeostasis and Diabetes
por: Zhang, Chenyang, et al.
Publicado: (2020)

The nuclear orphan receptor Nr4a2 induces Foxp3 and regulates differentiation of CD4(+) T cells
por: Sekiya, Takashi, et al.
Publicado: (2011)

Role of the Orphan Nuclear Receptor NR4A Family in T-Cell Biology
por: Odagiu, Livia, et al.
Publicado: (2021)

Rheumatic Manifestations and Diseases From Immune Checkpoint Inhibitors in Cancer Immunotherapy
por: Shen, Pan, et al.
Publicado: (2021)

Editorial: Omics for the objective diagnosis and management of immune-mediated rheumatic diseases
por: Fu, Tieh-Cheng, et al.
Publicado: (2023)

New insights at the interface between leprosy and immune-mediated rheumatic diseases
por: Cruz, Vitor Alves, et al.
Publicado: (2023)

NR4A3: A Key Nuclear Receptor in Vascular Biology, Cardiovascular Remodeling, and Beyond
por: Martínez-González, José, et al.
Publicado: (2021)

Nuclear Receptor 4a3 (Nr4a3) Regulates Murine Mast Cell Responses and Granule Content
por: Garcia-Faroldi, Gianni, et al.
Publicado: (2014)

Immunomics in Pediatric Rheumatic Diseases
por: Tay, Shi Huan, et al.
Publicado: (2019)

IL-33 in Rheumatic Diseases
por: Dong, Yuanji, et al.
Publicado: (2021)

Editorial: Innovation in Rheumatic Diseases
por: Jacinto, Maria João, et al.
Publicado: (2022)

Editorial: Rheumatic Diseases and Infection
por: Dong, Lingli, et al.
Publicado: (2022)

Drug Targeting of NR4A Nuclear Receptors for Treatment of Acute Myeloid Leukemia
por: Boudreaux, Seth P., et al.
Publicado: (2018)

Oncogenic Orphan Nuclear Receptor NR4A3 Interacts and Cooperates with MYB in Acinic Cell Carcinoma
por: Lee, David Y., et al.
Publicado: (2020)

Disruption of Beta-Cell Mitochondrial Networks by the Orphan Nuclear Receptor Nor1/Nr4a3
por: Close, Anne-Françoise, et al.
Publicado: (2020)

Cellular Uptake of Silica and Gold Nanoparticles Induces Early Activation of Nuclear Receptor NR4A1
por: Sousa de Almeida, Mauro, et al.
Publicado: (2022)

Refractory immune thrombocytopenia: Lessons from immune dysregulation disorders
por: Costagliola, Giorgio, et al.
Publicado: (2022)

Nuclear Receptor Rev-erb Alpha (Nr1d1) Functions in Concert with Nr2e3 to Regulate Transcriptional Networks in the Retina
por: Mollema, Nissa J., et al.
Publicado: (2011)

Piperlongumine is a ligand for the orphan nuclear receptor 4A1 (NR4A1)
por: Zhang, Lei, et al.
Publicado: (2023)

Effects of NR1 splicing on NR1/NR3B-type excitatory glycine receptors
por: Cavara, Nora A, et al.
Publicado: (2009)

Editorial: Comorbidity Burden in Rheumatic Diseases
por: Nikiphorou, Elena, et al.
Publicado: (2018)

Editorial: Nutrition and Metabolism in Rheumatic Diseases
por: Canhao, Helena, et al.
Publicado: (2019)

Editorial: Infection-Related Rheumatic Diseases
por: Thomas, Konstantinos, et al.
Publicado: (2021)

Co-activator candidate interactions for orphan nuclear receptor NR2E1
por: Corso-Díaz, Ximena, et al.
Publicado: (2016)

DNA methylation dysregulations in rheumatic heart valve disease
por: Shen, Kangjun, et al.
Publicado: (2017)

Rheumatic Fever and Rheumatic Heart Disease a Historical Perspective
por: Hajar, Rachel
Publicado: (2016)

Symphonien Nr. 3 & 4
por: Schubert, Franz, 1797-1828
Publicado: (1988)

The Nuclear Orphan Receptor NR2F6 Is a Central Checkpoint for Cancer Immune Surveillance
por: Hermann-Kleiter, Natascha, et al.
Publicado: (2015)

Modifier Genes as Therapeutics: The Nuclear Hormone Receptor Rev Erb Alpha (Nr1d1) Rescues Nr2e3 Associated Retinal Disease
por: Cruz, Nelly M., et al.
Publicado: (2014)

Editorial: Dysregulation of innate immunity in inflammatory skin disorders
por: Wang, Fang, et al.
Publicado: (2022)

Regulation of cAMP Responsive Element Binding Protein 3-Like 1 (Creb3l1) Expression by Orphan Nuclear Receptor Nr4a1
por: Greenwood, Michael P., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_n4b95fgvm95puapqj98702bocm